Resources | Blog

Looking ahead: Drug pricing in 2021 and beyond

2021 Drug Pricing Trend Report Cover

The past few months have been tumultuous ones for drug pricing policy. The year ahead also promises to bring plenty of significant developments as the Biden administration tackles drug pricing. 


In this report, we share four key drug pricing issues we’re keeping an eye on in 2021, plus our insights into how they might play out — and the operational impacts this could have for drug manufacturers. 


  • The future elimination of the Medicaid Rebate Cap

  • The unknown status of the Medicare Part D Rebate rule and Medicare Part B Most Favored Nation Drug Pricing Model

  • The fate of the newly established Administrative Dispute Resolution process and the ongoing contract pharmacy dispute in 340B 

The landscape for manufacturers is unpredictable. Learn what you need to know about potential changes ahead, and how your organization can be prepared for whatever the future holds. 


Download our trend report below to learn more.

Fill out the form below to download trend report now.

By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.